1 Min Read
June 21 (Reuters) - Pfizer Inc
* Pfizer receives expanded Health Canada approval for ibrance in hr+, her2- metastatic breast cancer Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.